BLCO executive granted 30,373 RSUs in Form 4

Bausch & Lomb Corp reported that President, Surgical, Luc Bonnefoy acquired 30,373 common shares through a grant of restricted share units (RSUs) at no cost per share.

Rhea-AI Filing Summary

Bausch & Lomb Corp reported that President, Surgical, Luc Bonnefoy acquired 30,373 common shares through a grant of restricted share units (RSUs) at no cost per share. These RSUs vest one-third on each of the first three anniversaries of the grant date. After this award, Bonnefoy holds 117,937 common shares directly.

Insider Trade Summary

Grant/Award: 30,373 shares

Grant/Award 1 txn

Insider Bonnefoy Luc

Role President, Surgical

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	30,373	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 117,937 shares (Direct)

Footnotes (1)

1. F1. Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did BLCO executive Luc Bonnefoy report in this Form 4?

Luc Bonnefoy reported receiving a grant of 30,373 restricted share units (RSUs) of Bausch & Lomb Corp common shares at no cost, increasing his direct holdings to 117,937 shares following the award under the company’s 2022 Omnibus Incentive Plan.

How many Bausch & Lomb (BLCO) shares were granted to Luc Bonnefoy?

Luc Bonnefoy was granted 30,373 restricted share units (RSUs) tied to Bausch & Lomb Corp common shares. These represent additional equity compensation and will convert into common shares as they vest, subject to continued service and plan terms.

What is the vesting schedule for Luc Bonnefoy’s BLCO RSU grant?

The 30,373 RSUs granted to Luc Bonnefoy vest in three equal installments. One-third vests on each of the first three anniversaries of the grant date, assuming he continues in service and complies with the 2022 Omnibus Incentive Plan and award agreement.

What is Luc Bonnefoy’s total BLCO share ownership after this grant?

Following the RSU grant, Luc Bonnefoy directly owns 117,937 Bausch & Lomb Corp common shares. This figure reflects his holdings after the 30,373-share award reported in the Form 4 insider transaction filing.

Did Luc Bonnefoy pay anything for the BLCO shares granted?

No cash was paid per share for this grant. The Form 4 shows a transaction price of 0.0000 per share, indicating the 30,373 RSUs were awarded as equity compensation rather than purchased in the open market.

Under which plan were Luc Bonnefoy’s BLCO RSUs granted?

The RSUs were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. This plan governs the vesting conditions and settlement of RSUs into common shares of Bausch & Lomb Corporation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 04:26 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bonnefoy Luc

(Last) (First) (Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN A6 L4K 4B4

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Surgical

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/25/2026		A		30,373(1)	A	$0	117,937	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

	/s/ Debra E. Levin, attorney-in-fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.